Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001578563-23-000001
Filing Date
2023-01-18
Accepted
2023-01-18 16:46:00
Documents
1
Period of Report
2023-01-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 9416
  Complete submission text file 0001578563-23-000001.txt   11731
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
Aceragen, Inc. (Issuer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4208 SIX FORKS ROAD, SUITE 920 RALEIGH NC 27609
Business Address 4208 SIX FORKS ROAD, SUITE 920 RALEIGH NC 27609 9194598620
NQ POF V GP, Ltd. (Reporting) CIK: 0001949220 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 23534924

Mailing Address 4208 SIX FORKS ROAD, SUITE 920 RALEIGH NC 27609
Business Address 4208 SIX FORKS ROAD, SUITE 920 RALEIGH NC 27609 9194598620
NovaQuest Co-Investment Fund XV, L.P. (Reporting) CIK: 0001949248 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 23534925